If You Invested in Alamar Biosciences (ALMR)
Looking for the current price? See the ALMR quote & overviewWhat $1,000 or $10,000 in ALMR Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Apr 17, 2026 |
|---|---|---|---|---|
| $1,000 | — | — | — | $1,123 +12% |
| $10,000 | — | — | — | $11,232 +12% |
Based on real historical closing prices, dividend- and split-adjusted, through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for ALMR$1,000 Investment Over Time
ALMR vs S&P 500Year-by-Year Returns
ALMR annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2026 | $22.00 | $24.71 | +12.3% | +12.3% |
About Alamar Biosciences
Laboratory Analytical Instruments · NASDAQ
Alamar Biosciences, Inc. develops proteomics technologies for protein detection and analysis. The company’s business centers on its NULISA technology, which stands for NUcleic Acid Linked Immuno-Sandwich Assay, and on a broader Precision Proteomics platform designed to detect and quantify protein biomarkers from small biofluid samples with high sensitivity and specificity.
Alamar sells instruments, consumables, and services based on its proteomic liquid biopsy platform. Its product portfolio includes NULISAseq panels, NULISAqpcr assays, and the ARGO HT fully automated, high-throughput system, which supports a sample-to-answer workflow. The company’s products are used in protein biomarker research, including applications tied to early disease detection and neurodegenerative disease research.
The company operates as a single-segment business focused on developing and commercializing protein-analysis tools. Its revenue model is tied to platform adoption, instrument sales, consumable usage, assay and panel offerings, and related services. Alamar’s customer base includes academic research institutions and biopharmaceutical organizations that use proteomics tools to study disease biology and biomarker signatures.
Alamar Biosciences is incorporated in Delaware and is headquartered in Fremont, California. Its common stock trades on the Nasdaq Stock Market under the symbol ALMR. The company completed its initial public offering in April 2026, after which it adopted amended and restated governing documents as a public company.
Frequently Asked Questions
Alamar Biosciences investment returns
How much would $1,000 invested in Alamar Biosciences be worth today?
Limited historical data is available for ALMR. The stock has been trading since 2026-04-17.
Has Alamar Biosciences outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare ALMR performance over available time periods.
What is Alamar Biosciences's average annual return?
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
